2-AG	2-arachidonoylglycerol
2-AGE	Noladin ether, 2-arachidonoylglycerylether
5-HT1A	5-hydroxytryptamine 1A receptor
5-HT2A	5-hydroxytryptamine 2A receptor
5HT3A	5-hydroxytryptamine 3A receptor
A	Adenosine receptor
ABHD6/12	α/β -hydrolase domain 6/12
AEA	Anandamide, arachidonylethanolamide
AIDS	Acquired immunodeficiency syndrome
CB1	Cannabinoid receptor 1
CB2	Cannabinoid receptor 2
CBC	Cannabichromene
CBCA	Cannabichromenic acid
CBD	Cannabidiol
CBD-BDS	Cannabidiol-botanical drug substance
CBDA	Cannabidiolic acid
CBDV	Cannabidivarin
CBG	Cannabigerol
CBGA	Cannabigerolic acid
CBN	Cannabinol
CBNA	Cannabinolic acid
CBNDA	Cannabinodiolic acid
CD	Crohn’s disease
CDAI	Crohn’s disease activity index
CHS	Cannabinoid hyperemesis syndrome
CNS	Central nervous system
COX	Cyclooxygenase
CRC	Colorectal cancer
DAG	Diacylglycerol
DAGL	Diacylglycerol lipase
DEA	Drug Enforcement Administration
DNBS	Dinitrobenzene sulphonic acid
DSS	Dextrane sulfate sodium
ECS	Endocannabinoid system, endogenous cannabinoid system
EFSA	European Food Safety Authority’s
EMT	Endocannabinoid membrane transporter
ENS	Enteric nervous system
EU	European Union
FAAH	Fatty acid amide hydrolase
FABP	Fatty acid binding protein
FDA	Food and Drug Administration
FUFOSE	Functional Food Science in Europe
GABA	γ -aminobutyric acid
GABAA	γ-aminobutyric acid type A receptor
GI	Gastrointestinal
GLP-1	Glucagon like peptide 1
GlyR	Glycine receptor
GPR	G protein-coupled receptor
GPX	Glutathione peroxidase
IBD	Inflammatory bowel disease
IBS	Irritable bowel syndrome
IBS-C	Irritable bowel syndrome with constipation
IBS-D	Irritable bowel syndrome with diarrhea
IBS-M	Irritable bowel syndrome with mixed bowel habits
IFN	Interferon
IL	Interleukine
i.p.	Intraperitoneal
iNOS	Inducible nitric oxide synthase
LES	Lower esophageal sphincter
LOX	Lipooxygenase
LPI	Lysophosphatidylinositol
LPS	Lipopolysaccharide
MAGL	Monoacylglycerol lipase
MAPK	Mitogen-activated protein kinase
MCP-1α	Monocyte chemoattractant protein-1α
MPO	Myeloperoxidase
NAAA	N-acylethanolamine acid amide hydrolase, N-acylethanolamine hydrolyzing acid amidase
NADA	N-arachidonoyldopamine
NAPE	N-acyl-phosphatidylethanolamine
NAPE-PLD	N-acyl-phosphatidylethanolamine-specific phospholipase D
NO	Nitric oxide
O-AEA	Virodhamine, O-arachidonoylethanolamine
OEA	Oleylethanolamide
PEA	Palmithoylethanolamide
PNS	Peripheral nervous system
PPARα	Peroxisome proliferator-activated receptor type-α
PPARγ	Peroxisome proliferator-activated receptor type-γ
ROS	Reactive oxygen species
SOD	Superoxide dismutase
THC	Δ9-tetrahydrocannabinol
THCA	Tetrahydrocannabinolic acid
TNBS	Trinitrobenzene sulfonic acid
TNF	Tumor necrosis factor
TRP	Transient receptor potential
TRPA1	Transient receptor potential cation channel subfamily ankyrin 1-type
TRPM8	Transient receptor potential cation channel subfamily M member 8
TRPV1	Transient receptor potential vanilloid type-1 channel
TRPV2	Transient receptor potential cation channel subfamily V member 2
TRPV3	Transient receptor potential cation channel subfamily V member 3
TRPV4	Transient receptor potential cation channel subfamily V member 4
UC	Ulcerative colitis
UGT	Upper gastrointestinal transit
USDA	United States Department of Agriculture
XIAP	X-linked inhibitor apoptosis
Δ9-THC-BDS	Δ9-tetrahydrocannabinol-botanical drug substance